Blood Flow Restriction Training for Post-Concussion Syndrome
Trial Summary
What is the purpose of this trial?
This trial is testing if Blood Flow Restriction (BFR) training can help patients aged 14-30 with symptoms after a concussion exercise more effectively. BFR uses a cuff to limit blood flow, making light exercises feel more intense. This could help these patients gain the benefits of exercise without worsening their symptoms. Blood Flow Restriction (BFR) training has been used to increase strength and muscle mass in various populations, including those with chronic conditions like multiple sclerosis and Parkinson's disease.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Blood Flow Restriction Training with Exercise for Post-Concussion Syndrome?
Blood Flow Restriction Training (BFR) has shown benefits in improving muscle strength, size, and aerobic performance in various populations, including those with neurological disorders and musculoskeletal issues. While specific data for post-concussion syndrome is limited, these findings suggest potential benefits for improving physical function and rehabilitation outcomes.12345
Is Blood Flow Restriction Training generally safe for humans?
How does Blood Flow Restriction Training with Exercise differ from other treatments for post-concussion syndrome?
Blood Flow Restriction Training (BFR) is unique because it involves performing low-intensity exercises while restricting blood flow to the muscles using a cuff, which can lead to strength gains and improved performance with less exertion compared to traditional high-intensity exercise. This approach is novel for post-concussion syndrome as it may offer rehabilitation benefits without the need for high physical stress, which is important for individuals recovering from concussions.311121314
Research Team
Laura Pietrosimone
Principal Investigator
Duke University
Eligibility Criteria
This trial is for English-speaking individuals aged 14-30 with Post-Concussion Syndrome, experiencing symptoms over four weeks and worsened by physical activity. It's not suitable for those with open wounds, clot history, circulation issues, sickle cell anemia, infections near the tourniquet area, cancer or lymph removal.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Initial Evaluation
Participants undergo a physical therapy concussion evaluation including orthostatic measurements, cervical screen, and vestibular-oculomotor screen. Initial questionnaires and heart rate variability are assessed.
Treatment
Participants perform exercises with and without blood flow restriction (BFR) to assess exercise tolerance and symptom provocation.
Follow-up
Participants are monitored for changes in post-concussion symptoms, global function rating, and heart rate variability.
Treatment Details
Interventions
- Blood Flow Restriction Training with Exercise
Find a Clinic Near You
Who Is Running the Clinical Trial?
Duke University
Lead Sponsor